The αvβ3 integrin, expressed on the surface of various normal and cancer cells, is involved in numerous physiologic processes such as angiogenesis, apoptosis, and bone resorption. Because this integrin plays a key role in angiogenesis and metastasis of human tumors, αvβ3 integrin ligands are of great interest to advances in targeted therapy and cancer imaging. In this report, one-bead one-compound (OBOC) combinatorial libraries containing the arginine-glycine-aspartic acid (RGD) motif were designed and screened against K562 myeloid leukemia cells that had been transfected with the human αvβ3 integrin gene. Cyclic peptide LXW7 was identified as a leading ligand with a built-in handle that binds specifically to αvβ3 and showed comparable binding affinity (IC 50 = 0.68 ± 0.08 μmol/L) to some of the well-known RGD "head-to-tail" cyclic pentapeptide ligands reported in the literature. The biotinylated form of LXW7 ligand showed similar binding strength as LXW7 against αvβ3 integrin, whereas biotinylated RGD cyclopentapeptide ligands revealed a 2-to 8-fold weaker binding affinity than their free forms. LXW7 was able to bind to both U-87MG glioblastoma and A375M melanoma cell lines, both of which express high levels of αvβ3 integrin. In vivo and ex vivo optical imaging studies with the biotinylated ligand/streptavidin-Cy5.5 complex in nude mice bearing U-87MG or A375M xenografts revealed preferential uptake of biotinylated LXW7 in tumor. When compared with biotinylated RGD cyclopentapeptide ligands, biotinylated LXW7 showed higher tumor uptake but lower liver uptake. Mol Cancer Ther; 9(10); 2714-23. ©2010 AACR.
Introduction
The αvβ3 integrin serves as a receptor for a variety of extracellular matrix proteins displaying the arginine-glycineaspartic acid (RGD) tripeptide sequence (1) . The integrin, expressed on the surface of various normal and cancer cells, is involved in multiple physiologic processes, including angiogenesis, apoptosis, and bone resorption. Because this integrin plays a key role in angiogenesis and metastasis of human tumors, αvβ3 integrin ligands are of great interest to advances in targeted therapy and cancer imaging. The RGD motif was described in the early 1980s by several groups such as Michael D. Pierschbacher and Erkki Ruoslahti (2) . Many RGD analogues have been designed and synthesized (3) since then, and many naturally occurring snake venoms also contain a RGD motif (4) . Phage-display peptide library screening has been used to identify peptide ligands targeting various integrins, thereby elucidating unique integrin or tissue-targeting peptides. With the use of this screening methodology, the nonapeptide CDCRGDCFC was identified to be highly selective against αv integrins (5) . Another "design approach" based upon "spatial screening" of cyclopeptides, in which conformational change is induced by variation of the ring size, amino acid chirality, and retro-inverso structures, N-methylation of peptide backbone, or introduction of constraining structural elements, has led to the discovery of cilengitide (3, 6, 7) . This cyclic peptide, cyclo (RGDf-N(Me)V-), binds strongly and relatively selectively to the αvβ3 integrin, and is now in clinical trials for the treatment of several different kinds of cancers (8) . However, due to intrinsic constraints of these screening processes, either only L-amino acid residues can be included in the phage-display peptide libraries or the number of peptides that can be simultaneously tested in the spatial screening process is rather limited. Here we report on the use of the one-bead one-compound (OBOC) combinatorial library method (9) to identify high-affinity ligands specifically targeting the αvβ3 integrin. The OBOC library is synthesized on beads using the "split-mix" method such that each bead displays only one chemical entity. The resin is grafted with polyethylene glycol linkers, which act as a built-in handle for library compounds. Combined with whole cell binding assays, OBOC permits rapid synthesis and high-throughput screening of millions of peptides and/or synthetic small molecules, with various structures and conformations, for their ability to bind to unique target proteins on the cancer cell surface. With the use of this technique, several important ligands against different tumor cell surface integrin receptors have been identified in recent years; these include LLP2A which targets the α4β1 integrin (10) , and OA02 (11), LXY1 (12) , and LXY3 (13) which bind the α3β1 integrin. Here, OBOC combinatorial libraries bearing the RGD and related motif were designed, synthesized, and screened against αvβ3 integrin receptor-transfected K562 myeloid leukemia cells. A novel cyclic RGD peptide, cGRGDdvc (LXW7), cyclized by a disulfide bond and with a built-in handle at the carboxyl terminus, was identified and subsequently shown to possess high binding affinity and specificity against the αvβ3 integrin. Furthermore, in vivo and ex vivo imaging experiments indicated that the LXW7-biotin/streptavidin-Cy5.5 complex was able to target U-87 MG glioblastoma and A375M melanoma xenografts with high efficiency and low liver uptake.
Materials and Methods

Synthesis of the focused OBOC libraries
The OBOC libraries were synthesized on TentaGel S NH 2 resin using the bilayer bead encoding strategy (14) and the split-mix method (9) . A typical synthetic cycle utilizing the split-mix approach is described as follows: beads are split into aliquots as desired, each aliquot of beads is coupled with a specific Fmoc-protected amino acid in the presence of 1-hydroxybenzotriazole/1, 3-diisopropylcarbodiimide for 2 hours, and all aliquots of beads are mixed together and washed five times with N,N-dimethylformamide (DMF). Coupling completeness and Fmoc deprotection are monitored by the Kaiser test. For Fmoc deprotection, beads are incubated twice (15 minutes each) with 20% 4-methyl piperidine solution in DMF and then thoroughly washed three times each with DMF, methanol, and DMF, respectively. For Alloc deprotection, the beads are incubated with Pd(PPh 3 ) 4 (0.2 equivalent) and PhSiH 3 (20 equivalent) in dichloromethane for 30 minutes (twice) and washed 3 times with 0.5% diethyldithiocarbamic acid sodium salt in DMF and 10 times in DMF. The structures of libraries 1 to 4, the used amino acids, and detailed synthesis procedures for the libraries are described in Supplementary Materials and Methods (Supplementary  Tables S1 and S2 and Supplementary Scheme S1).
Cells
We 
Whole cell binding assay and bead screening
The cells were collected and cell pellets were resuspended with 10 mL growth medium in a 10-cm Petri dish. Thereafter the beads were incubated with suspended cells, and the whole dish was kept shaking at a speed of 40 rpm inside a 37°C incubator under 5% CO 2 . Beads showing stronger binding were picked up, washed with 8 mol/L guanidine chloride, watered sequentially, and finally sequenced with ABI protein sequencer (Model 494).
Docking simulation study
Conformations for LXW7 were generated from replicaexchange molecular dynamics simulation (details in Supplementary Materials and Methods; ref. 15 ). The structures from dynamics studies were clustered using multiscale modeling tools for structural biology (16) , and representative structures were taken from the main clusters. The peptide cyclo(RGDfV) and LXW7 were each docked into the RGD binding site of integrin αvβ3 (PDB ID 1L5G; ref. 17) using the program Autodock 3.05 (18) . Amber charges (19) were assigned to the ligand using the program Chimera (20) . Kollman-united atom charges were used for the protein (21) . A 80 × 80 × 90 grid was used with a spacing of 0.375 Å. The grid was centered in the middle of the binding sites. A Lamarckian algorithm was used to generate conformations for the ligand within the active site. The parameters used for the Lamarckian genetic algorithm were the same as reported by Legge et al., except that the maximum number of energy evaluations was 250,000 (22) . A total of 1,000 conformers were generated for the ligand in the binding sites. The conformers were clustered using a 2.0 Å root-mean-square deviation.
Synthesis of free form and biotinylated form of RGD peptides
Cyclo(RGDfE), cyclo(RGDyK), and cyclo(RGDfK) were obtained from Peptides International. Cyclic peptides were synthesized on Rink amide resin (loading 0.59 mmol/g), using 1-hydroxybenzotriazole/1, 3-diisopropylcarbodiimide as coupling reagents. Threefold molar excess of Fmoc-protected amino acids to resin was used for coupling. Coupling completeness and Fmoc deprotection were monitored by ninhydrin test (Supplementary Materials and Methods).
Flow cytometry
Echistatin is a 49-amino-acid peptide belonging to the family of disintegrins. It binds to the αvβ3 integrin with high affinity and can efficiently compete with linear and cyclic peptides containing the RGD sequence. For the determination of half-maximum binding inhibition concentration (IC 50 ) of all the RGD peptides, peptides at different concentrations were premixed with 2 μmol/L echistatin-FITC, incubated with 3 × 10 5 αvβ3-K562 and K562 cells separately in 100 μL binding buffer (1 × PBS containing 10% fetal bovine serum and 1 mmol/L MnCl 2 ) for 30 minutes on ice, and evaluated with flow cytometry. In this assay, there was background binding from echistatin-FITC to K562 cells. However, all these tested peptides had no inhibition effect to the background binding.
The cell staining with biotinylated LXW7 (LXW7-Bio) was conducted as follows. LXW7-Bio (1 μmol/L) was incubated with 3 × 10 5 cells on ice for 30 minutes in binding buffer. The samples were washed three times with 1 mL washing buffer (1 × PBS containing 1% fetal bovine serum) and incubated with 1:500 dilution of streptavidinphycoerythrin (PE; 1 mg/mL) for 30 minutes on ice. After one additional wash, samples were tested by flow cytometry.
To test the expression of the αvβ3 integrin on U-87MG and A375M, samples were stained with 1 μg mouse antihuman αvβ3-PE (23C6, Santa Cruz Biotechnology, Inc.) on ice for 30 minutes, washed once with washing buffer, and evaluated by flow cytometry. For the blocking experiment, 10 μg antihuman αvβ3 (LM609, Chemicon) were premixed with 1 μmol/L LXW7-Bio and incubated with cells, followed by streptavidin-PE incubation and detection with flow cytometry.
The samples were analyzed with Coulter XL-MCL Flow Cytometry. The histogram and mean fluorescence intensity (MFI) were determined. The IC 50 measurements were calculated using Graph Prism software (www.graphpad.com).
Tumor xenografts
Animal studies were done according to approved protocol by the Institutional Animal Care and Use Committee of the University of California, Davis. Female athymic Small letters indicate D-amino acids. *Library 1 (8 mer) was synthesized on TentaGel beads using the split-mix synthetic method. Libraries 3 and 4 were constructed using topological segregated bilayer beads, in which 80% of the outer layer (16% of total loading) was blocked by acetylated glycine; then the library was constructed on the rest of 20% of the outer layer (4% of total loading). The building blocks on different positions are: X + : R, K and Orn. X − : Asp, Glu, Aad and Bec. X K : K and Orn. 
In vivo and ex vivo mouse optical imaging
The mice were anesthetized by injection of 30 μL Nembutal (50 mg/mL) prior to optical imaging. Tetravalent peptide-biotin-streptavidin complex (1.8 nmol), prepared by mixing 7.2 nmol of biotinylated peptide with 1.8 nmol of streptavidin-Cy5.5 in PBS overnight at 4°C, was injected via the tail vein. Images were acquired with a Kodak IS2000MM Image station with excitation filter 625/20 band pass, emission filter 700WA/35 band pass, and 150 W quartz halogen lamp light source set to maximum. Six hours postinjection, a second series of images was captured. The mice were sacrificed and the organs were excised for ex vivo imaging. Data were collected and analyzed using the Kodak ID 3.6 software by drawing the region of interest on the image.
Data processing and statistics
We calculated MFIs of the tumor by means of the region-of-interest function using Kodak 1D Image Analysis Software (Kodak). All the data are shown as mean ± SD of n independent measurements. Student's t-test was used for statistical analysis of ex vivo imaging intensity. Statistical significance was indicated by P < 0.05 and P < 0.01.
Results
The screening of RGD-containing OBOC libraries against the αvβ3 integrin
In our initial study, HUVEC were used as a neovasculature cell model (23) to identify peptide ligands against newly formed tumor blood vessels. Two cyclic RGDcontaining peptide libraries, octamer library 1 (Table 1)  and nonamer library 2 (Supplementary Table S1 ), were synthesized and screened against HUVEC using a whole cell binding assay (9) . Library 1 elicited stronger binding with HUVEC than did library 2, and was therefore used for further screening analysis. As shown in Table 1 , RGD was found to be the preferred motif for HUVEC binding with library 1. At the x 2 , x 6 , and x 7 positions, however, there were no obvious preferences for any specific amino acid. Considering the broad binding profile of the RGD motif (24) against several known integrins, some of which are expressed on the surface of HUVEC (25) , the varied sequence results obtained were therefore not particularly surprising. The αvβ3 integrin has been reported as the major integrin expressed in neovasculature (26, 27) . We therefore hypothesized that cells expressing high levels of the αvβ3 integrin would be a more appropriate cell model for identifying ligands that bind specifically to neovasculature. The αvβ3 integrin-transfected K562 leukemia cells, expressing a high level of the αvβ3 integrin and a baseline level of the α5β1 integrin (expressed by the parent cell line), were used as a living cell probe to screen library 1 ( Supplementary Fig. S1 ). As shown in Table 1 , this experiment yielded Gly as the preferred amino acid at the x 2 position (60%), and D-Asp occurred with increased frequency (40%) at the x 6 position. As a control, library 1 was also screened with the parent cell line (nontransfected K562 cells), which yielded a higher frequency of D-Lys and D-Arg (57%) at the x 2 position.
We had previously shown that reduction of ligand loading on the bead surface increases the screening stringency and therefore facilitates the identification of more potent ligands (28) . To further explore the amino acid preferences flanking the RGD motif, library 3, with 20% down-substitution of bead surface to facilitate an expected higher screening stringency, was synthesized and screened with αvβ3-K562 cells. Under this higher stringency screening condition, 100% of the peptides from library 3 yielded Gly at the x 2 position with an acidic amino acid D-Asp or D-Glu at either position x 6 (40%) or x 7 (20%; Table 1 ). Polar amino acids D-Asn, D-Gln, and DThr were also found to be predominant at the x 6 position (40%). The cGRGDdvc sequence occurred twice. Other than the 20% acidic residues, there was no obvious preference in the x 7 position.
To further narrow down the amino acid preferences at the x 6 and x 7 positions, we designed and synthesized library 4, in which at "X K" position only Lys and Orn were used as building blocks. Our assumption was that by changing the RGD motif to a weaker but related motif, such as lysine-glycine-aspartic acid, the screening stringency on the x 2, x 6 , and x 7 positions would be increased. The screening results showed that Gly was still preferred in x 2 , the acidic amino acids (D-Asp and D-Glu) appeared with higher frequency (63%) at the x 6 position, and more polar (including acidic residues) and hydrophobic amino acids occurred in the x 7 position. Interestingly, the sequence cGKGDdvc was found as expected, and two other sequences, cGKGDsec and cGKGDdsc, appeared twice independently.
Binding affinity of leading peptides Based on the screening results shown above, LXW1-8 peptides (Supplementary Table S3 ) were selected for further binding affinity analysis (Table 2) . LXW1, LXW2, LXW4, LXW6, LXW7, and LXW8 were selected directly from the data compiled in Table 1 ; LXW3 and LXW5 were derivatives of LXW4 and LXW6, respectively, with Lys changed to Arg at the third position. The IC 50 measurements of the peptides inhibiting the echistatin-FITC binding with αvβ3-K562 were determined. The results showed that LXW7 (Fig. 1A) had the highest binding affinity to the αvβ3 integrin with IC 50 at 0.68 ± 0.08 μmol/L. LXW3 showed similar affinity. The binding affinities of LXW1, LXW2, and LXW5 were found to be two to four times lower than that of LXW7. Changing of Arg to Lys in the "X K" position in LXW4, LXW6, and LXW8 decreased the affinity dramatically. These findings validated the rationale for the library 4 design and confirmed that replacement of Arg by Lys in the "X K" position greatly increased the selection stringency of the amino acids adjacent to the RGD motif.
Binding characterization of LXW7 and biotinylated LXW7
Of the eight peptides tested, LXW7 had the highest binding affinity against the αvβ3 integrin. To test its specificity, LXW7 was prepared in biotinylated form (Fig. 1B) and incubated with αIIbβ3-, αvβ5-, and αvβ3-transfected K562 and parent K562 cells (α5β1), followed by incubation with streptavidin-PE. The peptide binding was tested by flow cytometry. The results show that LXW7 bound strongly to αvβ3-K562 cells and weakly to αvβ5-K562 cells and αIIbβ3-K562 cells, and did not bind to K562 cells (Fig. 1C) . Several other integrins, such as αvβ1, αvβ6, αvβ8, and α8β1, have been reported to bind to ligands via the RGD sequence as well (29) . Further studies on LXW7 binding specificity against these integrins will be Figure 1 . A, structure of LXW7. B, structure of biotinylated LXW7. C, series of integrin-transfected K562 cells were stained with LXW7. Samples with black curves were treated with 1 μmol/L LXW7-biotin and detected with flow cytometry. Red curves, samples without treatment of LXW7-biotin and as negative controls. LXW7 showed remarkable positive binding with αvβ3, very weak cross-reactivity with αvβ5 and αIIbβ3, and no binding with α5β1.
addressed in future experiments when those transfected cell lines become available. RGD peptides targeting the αvβ3 integrin have been studied and developed for many years. Cyclic pentapeptides such as cyclo(RGDfV) were found to show high binding affinity to the αvβ3 integrin. Furthermore, the cyclo(RGDf-N(Me)V-) analogue showed even higher binding capability and selectivity against the αvβ3 integrin. Cyclic peptides such as cyclo(RGDfE), cyclo(RGDfK), and cyclo(RGDyK) were commonly used to carry optical imaging probes or radiometal chelates to target the αvβ3 integrin on tumor cells. The binding affinities of LXW7 and these cyclic RGD pentapeptides against the αvβ3 integrin were compared based on their ability to inhibit echistatin-FITC binding against αvβ3-K562. The binding affinity of LXW7 was found to be two to three times lower than that of cyclo(RGDyK) and cyclo(RGDf-N(Me)V-) but similar to that of cyclo(RGDfV), cyclo(RGDfE), and cyclo(RGDfK) ( Table 2) .
To use these cyclic peptides for imaging and drug delivery, one will need to tether these ligands to the payload. Because LXW7 was discovered through screening OBOC combinatorial libraries with an on-bead binding assay, LXW7 already has a built-in handle at the COOH-terminus to which the library compound was linked to the bead. Therefore, biotinylation can be conveniently carried out at the COOH-terminus of the ligand. In contrast, peptide cyclo(RGDf-N(Me)V-) or cyclo (RGDfV) lacks a handle because of head to tail cyclization. Consequently, Val was replaced with either Lys or Glu, to which the payload can be covalently linked. However, such linker can potentially affect the binding of the ligand to the integrin. We prepared cyclo(RGDyK), cyclo(RGDfK), and cyclo(RGDfE) with biotin attached to either Lys or Glu residues via a hydrophilic linker (Supplementary Fig. S2 ). We then determined the binding affinity of each of these biotinylated forms and compared them with the corresponding nonbiotinylated forms. Not unexpectedly, LXW7 and biotinylated LXW7 were found to have near identical binding strength to the αvβ3 integrin. However, biotinylation of other pentapeptides resulted in a 2-to 8-fold decrease in affinity (Table 2) .
Docking simulation study on LXW7
To further explain the binding specificity of LXW7 against the αvβ3 integrin, molecular docking calculations were carried out (Fig. 2) . The crystal structure of the αvβ3 integrin contains the ligand cyclo(RGDf-N (Me)V-), but for our docking simulations the analogous ligand cyclo(RGDfV) was used for ease of building. In docking simulations, many different clusters of conformations are obtained and choosing the binding conformation is not always obvious. To aid in determining the correct conformation, the ligand has to be interacting with the ion in the metal ion-dependent adhesion site (MIDAS) and also interacting with an Asp in the α subunit. In all crystal structures of integrins with a ligand, these two conditions are always fulfilled. One of the lowest energy clusters of LXW7 was able to interact with the carboxylate side chain of Asp218 in the α-subunit and coordinate to the Mg 2+ in the MIDAS site of the β-subunit (Fig. 2A) . Although LXW7 and cyclo (RGDfV) bind to the same site and the Val side-chain in LXW7 is also in an almost identical position to the phenylalanine side-chain in cyclo(RGDfV), the conformation of the RGDs and the ligands in general are different. Firstly, The LXW7 peptide forms a bowl-like conformation where glycine in the RGD has a kinked structure ( Fig. 2A) and the orientation of the Arg side-chain with Asp218 (α-subunit) is not optimal (Fig. 2D) although the Asp can interact with Mg 2+ easily (Fig. 2B) . Secondly, the D-Asp is able to form a salt bridge with Arg214 in the β-subunit (Fig. 2B and C) and the COOH-terminal carbonyl oxygen is able to coordinate to a Ca 2+ in the site adjacent to MIDAS in the β-subunit. This additional interaction probably contributes to the specific binding of LXW7. Thirdly, the calculated interaction energy for LXW7 (−18.70 kcal/mole) to the αvβ3 integrin is even greater than the calculated interaction energy for the well-known ligand cyclo (RGDfV) (−15.07 kcal/mole), which indicates that LXW7 bears a better conformational fit in the binding site. Lastly, having D-Ala instead of Gly preceding RGD did not change the docking conformation of LXW7, although experimentally it was shown that Gly was highly favored. The molecular dynamics may provide a possible reason for the difference in binding preference. Measuring the α carbon distance between Arg and Asp of RGD within LXW7 (cGRGDdvc) and caRGDdvc shows there is a difference in the dynamics of these two peptides. The distance between the α carbons of Arg and Asp of cGRGDdvc was consistently larger and showed greater fluctuations than caRGDdvc (Supplementary Table S4 ). This implies that both the conformational preference and flexibility of cGRGDdvc differs from caRGDdvc.
LXW7 binds tumor cells with αvβ3 integrin expression
Many different cancer cells such as glioblastoma (U-87 MG) and melanoma (A375M) express the αvβ3 integrin on their cell surface. LXW7 was expected to bind these cells and could be used as a targeting agent. As shown in Fig. 3A and C, both tumor cells express the αvβ3 integrin, and the binding of biotinylated LXW7 against the integrin was blocked significantly by anti-αvβ3 integrin (Fig. 3B and D) . The binding affinity of LXW7 against U-87MG, A375M, and αvβ3-K562 cells was tested. All three cell lines were found to have similar binding constants in the range of 72 to 89 nmol/L (Supplementary Table S5 ).
In vivo and ex vivo targeting effect of LXW7 against tumors in xenografts on nude mice
The in vivo targeting effect of LXW7 was further shown in nude mice implanted s.c. with U-87MG and A375M xenografts. The tetravalent imaging complex LXW7-biotin-streptavidin-Cy5.5 was found to accumulate specifically in the xenografts compared with the streptavidin-Cy5.5 control (Fig. 4A and B) . Besides the high signal uptake in xenografts, the kidney was the only organ showing obvious accumulation of the imaging probe. These data indicate that LXW7 has the ability to carry optical imaging dye to target tumors expressing the αvβ3 integrin. Confocal microscopy of U-87MG xenograft cryosections revealed that LXW7 also distributed on the neovasculature with CD31-positive expression ( Supplementary Fig. S3 ). This finding further validated the targeting properties of LXW7 against tumor cells and newly formed blood vessels expressing the αvβ3 integrin.
RGD peptides have been generally reported as the targeting ligands against the αvβ3 integrin. The tumortargeting ability of biotinylated LXW7 and several "head-to-tail" cyclic RGD pentapeptides were also compared in a U-87 MG xenograft mouse model. Ex vivo imaging showed that LXW7-Bio had higher tumor uptake than cyclo(RGDfE)-Bio, cyclo(RGDfK)-Bio, and cyclo(RGDyK)-Bio ( Fig. 4C and D) . Furthermore, the liver uptake from LXW7-Bio was near control level (streptavidin-Cy5.5 without peptide), whereas the signals from the cyclic RGD pentapeptides in liver were much higher ( Fig. 4C and D) . These results indicate that the biotinylated RGD cyclopentapeptides have much higher nonspecific accumulation in the liver. 
Discussion
The αvβ3 integrin receptor has received much clinical interest as a cancer target because the integrin expression correlates well with tumor progression and invasiveness of melanoma, glioma, and lung and breast cancers (30) (31) (32) (33) (34) . Furthermore, the αvβ3 integrin is overexpressed on activated endothelial cells of tumor neovasculature, but is underexpressed in quiescent endothelial cells of most normal tissues and organs (27, 35) . Therefore, there is a critical need to identify ligands targeting the αvβ3 integrin with high binding affinity and specificity for cancer diagnosis and therapy (36) (37) (38) . The RGD motif is the most common integrin binding sequence found within many extracellular matrix proteins and disintegrins (39, 40) . However, different integrins recognize diverse RGD-containing proteins and peptides. The binding affinity and specificity are modulated by the amino acid residues adjacent to the RGD triad, the auxiliary binding motifs in the ligand, and to a large extent by the conformational presentation of the triad. In this report, we have shown that through screening OBOC libraries with RGD and related motif against the αvβ3 integrin, one will be able to narrow down the possible amino acids flanking RGD and discover specific ligands with higher affinity and selectivity.
To focus our discovery effort on ligands against one specific integrin each time, we used αvβ3-transfected K562 cells and K562 parent cells as the screening probes. We designed and synthesized RGD-containing OBOC Figure 4 . In vivo and ex vivo near-IR fluorescent imaging on nude mice implanted with xenografts. Six hours after tail vein injection with streptavidin-Cy5.5 alone or biotinylated LXW7-streptavidin-Cy5.5 complex, kidney uptake was high in both mice, but preferential uptake into the U-87MG tumor (A) and A375M (B) were noted in mice given biotinylated LXW7-streptavidin-Cy5.5 complex. The images shown represent one of three groups. Ex vivo imaging of U-87MG xenograft bearing nude mice after injection of streptavidin-Cy5.5-biotinylated LXW7 and cyclic RGD pentapeptides [cyclo(RGDfE), cyclo(RGDfK), and cyclo(RGDyK)] is shown in C. LXW7 exhibited high tumor uptake with low liver uptake (C). The reverse was true for the other three cyclic RGD pentapeptides. Relative fluorescence uptake by tumor and liver (C) was quantified in D. Streptavidin-Cy5.5 alone without peptide was utilized as control. A.U., arbitrary unit. combinatorial cyclic peptide libraries (libraries 1 and 2) with 100% bead surface substitution for initial screening. The use of a 20% down-substitution beads library (library 3) and a library without RGD motif (library 4) further narrowed down the amino acid possibility on the flanking positions of RGD triads. Finally, the amino acids in the x 2 , x 6 , and x 7 positions displayed much more restrictive sequences. Gly was almost exclusively preferred at the x 2 position. The x 6 position had more acidic amino acids (D-Asp and D-Glu, 63%), which according to the docking data for LXW7, are very important for peptideintegrin binding. The x 7 position preferred polar and hydrophobic amino acids. Partly in agreement with our findings, other groups also reported the high frequency appearance of Gly in the amino side of the RGD triad with phage-display screening and solid-phase integrin inhibition assay, but few of them mentioned the residue preference at the carboxyl side of the triad (41) (42) (43) (44) . The requirement of Gly in the amino side of RGD in LXW7 might be due to the need for flexibility (45) to adopt many different conformations to fit in the binding site. This was further supported by the molecular dynamics study on LXW7, in which cGRGDdvc showed greater conformational preference and flexibility than did caRGDdvc (Supplementary Table S4 ). Overall, our results indicate an amino acid residue preference around the RGD motif as shown by selective binding of peptides with expanded lateral sequence.
Peptides with a RGD motif or peptidomimetics against the αvβ3 integrin (46) have been utilized as probes for tumor imaging and for monitoring therapeutic response to antiangiogenic agents. We focused on RGD peptide ligands and compared LXW7 with several other well-known RGD ligands. The majority of peptide imaging agents have been developed based on the cyclo(RGDfV) template. Because it is a head-to-tail cyclic peptide and the Asp side chain is critical for receptor binding, one will need to modify the peptide to introduce a handle for covalent attachment of the imaging probes such as fluorophor or radiometal chelate. Cyclo(RGDfK), cyclo(RGDfE), and cyclo(RGDyK) are the most common RGD cyclopentapeptides reported in the literatures in which the Val was replaced by either Lys or Glu. Using a competitive assay, we determined that the binding affinity of LXW7 is similar to that of cyclo(RGDfK) and cyclo(RGDfE), and about two times lower than that of cyclo(RGDyK) ( Table 2) . Because peptide cyclo(RGDfV) has been optimized in size to fit the binding pocket of the αvβ3 integrin, introduction of any labeling groups to the side chain of amino acid Lys or Glu (in replacement of Val) would likely be within close proximity to the integrin recognizing RGD moiety, resulting in decreased receptor binding affinity and specificity (47) . In contrast, incorporation of payloads at the carboxyl end of the LXW7 peptide would avoid the potential adverse effects to receptor binding owing to the large distance between the linker and the binding region of the peptide. We compared the targeting efficacy between LXW7 and the three RGD cyclopentapeptides. In contrast to the zero interference effect from biotinylation of LXW7, the biotinylation of the three RGD cyclopentapeptides showed a 2-to 8-fold decrease in binding affinity when compared with their free forms and 2 to 8 times lower binding affinity than biotinylated LXW7 (Table 2 ). These findings were further supported by optical imaging studies on a U-87MG nude mouse xenograft model, in which the biotinylated LXW7 exhibited better tumor targeting than the three biotinylated cyclopentapeptides.
Furthermore, the undesirable liver uptake of biotinylated LXW7 was significantly lower than other cyclopentapeptides. There have been several reports on high uptake of radiolabeled cyclo(RGDfE), cyclo(RGDfK), or cyclo(RGDyK) into the liver (47) (48) (49) . The mechanism underlying the different liver uptake profiles between biotinylated LXW7 and the biotinylated cyclopentapeptides have yet to be determined. The enhanced hydrophilicity of LXW7 as a result of an extra D-Asp adjacent to the RGD motif may perhaps partly decrease the hepatobiliary clearance of the peptide. Further biodistribution studies based upon LXW7 radioconjugates should help clarify this issue.
In conclusion, the OBOC combinatory library method has again lent itself as a powerful tool to identify and optimize specific ligands against cell surface receptors. In this report, a novel peptide ligand, LXW7 with a RGD motif, was identified using OBOC combinatorial chemistry. The positions flanking the RGD motif were restricted to certain amino acids specific for binding with the αvβ3 integrin. LXW7 showed high targeting efficacy and specificity for the αvβ3 integrin expressed in tumor cells and neovasculature. Moreover, LXW7 permits easy functionalization for payload conjugation without attenuating the binding affinity of the peptide. For these reasons, LXW7 has great potential as a highly efficient peptide ligand for targeted imaging and drug delivery.
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